|
Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
|
4
|
Zenith Epigenetics
|
Mar 03, 2017 10:01AM
|
|
Re: ASCO 2019 coming up May 31 to June 4
|
4
|
Zenith Epigenetics
|
May 27, 2019 03:38PM
|
|
Re: Financial Statement Q2, 2023 /MD&A
|
4
|
Resverlogix Corp.
|
Aug 13, 2023 04:18PM
|
|
Re: What is Mr. Market saying about RVX?
|
4
|
Resverlogix Corp.
|
Nov 26, 2018 10:46AM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
4
|
Zenith Epigenetics
|
Jul 16, 2017 01:18PM
|
|
Re: ZHCLF
|
4
|
Zenith Epigenetics
|
Feb 06, 2024 11:23AM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
4
|
Resverlogix Corp.
|
May 09, 2022 12:27PM
|
|
Re: here's one of the newswires
|
4
|
Resverlogix Corp.
|
Jan 12, 2018 12:19PM
|
|
Re: Why have we not heard more about CURATE-AI?
|
4
|
Zenith Epigenetics
|
Mar 25, 2021 05:40PM
|
|
Re: Zenith trial partners
|
4
|
Zenith Epigenetics
|
Jan 29, 2023 03:42PM
|
|
Re: 47 Taken out by Gilead for $4.9 billion
|
4
|
Resverlogix Corp.
|
Mar 05, 2020 09:14AM
|
|
Re: Questions for Q1 webcast
|
4
|
Resverlogix Corp.
|
Mar 05, 2016 09:08PM
|
|
Re: Reading (parsing, fantasizing) the tea leaves
|
4
|
Resverlogix Corp.
|
Feb 01, 2021 10:28AM
|
|
Re: Value
|
4
|
Resverlogix Corp.
|
Jan 20, 2017 09:49PM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
4
|
Zenith Epigenetics
|
Apr 14, 2022 06:46AM
|
|
Canadian government support for business
|
4
|
Resverlogix Corp.
|
May 11, 2020 03:10PM
|
|
Re: MERCK….
|
4
|
Resverlogix Corp.
|
Oct 04, 2021 11:17AM
|
|
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
|
4
|
Zenith Epigenetics
|
Aug 06, 2019 11:32AM
|
|
Re: TD & Zen over the weekend..
|
4
|
Resverlogix Corp.
|
Aug 12, 2019 02:46PM
|
|
Re: Conspiracy Theory(s) do things like this happen?
|
4
|
Resverlogix Corp.
|
Jan 19, 2023 02:44PM
|
